News summary

Wanfu Biotech: U.S. subsidiary Sanlian Home Self-Test OTC products obtained authorization from U.S. FDAEUA Securities Times e Company News, Wanfu Biotech announced on the evening of May 5 that WondfoUSacco, a wholly owned subsidiary of Wanfu Biotech in the United States70jilicom., Ltd recently received a receipt from the U.S. Food and Drug Administration ("FD...

Newsletter text

Wanfu Biotech: U.S. subsidiary Sanlian Home Self-test OTC products obtained authorization from the U.S. Securities Times e Company News, Wanfu Biotech announced on the evening of May 5 that WondfoUSACo., a wholly owned subsidiary of Wanfu Biotech in the United States, Ltd recently received a notice from the U.S. Food and Drug Administration ("FDA") that Wanfu Biotech's American subsidiary70jilicomNew Coronavirus, Influenza A and Influenza B Triple Home Test Kit (OTC version) WELLlife? COVID-19/InfluenzaA&BHomeTest received FDA Emergency Use Authorization (EUA). After the above products are OTC authorized by FDAEUA, those in need can purchase them without a prescription. The company can sell the products through e-commerce, pharmacies, supermarkets and other channels in the United States, and can be self-tested at home.

(: Congratulations